Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02860871
Other study ID # 35RC13_8815
Secondary ID
Status Completed
Phase N/A
First received July 25, 2016
Last updated April 24, 2017
Start date June 2014
Est. completion date December 2016

Study information

Verified date July 2016
Source Rennes University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The main objective of this study is to assess the ability of Fiber-optic Evanescent Wave Spectroscopy (FEWS) to discriminate synovial fluids samples of septic arthritis patients from other causes of joint effusion by analyzing ex vivo joint fluid samples collected during routine clinical care.


Recruitment information / eligibility

Status Completed
Enrollment 611
Est. completion date December 2016
Est. primary completion date August 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- patients benefiting from joint fluid puncture for diagnostic purposes in the rheumatology hospitals participating in the study

- patients over 18 year old,

- patients who received information about the protocol and have not expressed opposition to participate.

Exclusion Criteria:

- patients opposing the study,

- patients aged below 18 year old

- Protected major (safeguard justice , trusteeship and guardianship) and persons deprived of liberty

Study Design


Related Conditions & MeSH terms


Intervention

Other:
infrared spectroscopy


Locations

Country Name City State
France CHU de RENNES Rennes

Sponsors (1)

Lead Sponsor Collaborator
Rennes University Hospital

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Diagnosis of the cause of joint effusion The final diagnosis of the cause of joint effusion is made by the clinician based on the clinical and laboratory data : septic arthritis or other causes of arthritis. through study completion, an average of 6 months
See also
  Status Clinical Trial Phase
Completed NCT04004962 - Use of Infrared Spectroscopy in Fast Septic Arthritis Diagnosis
Completed NCT03979937 - Development and Validation of a Simple Diagnostic Tool Predictive of the Aseptic Character of Joint Effusion